The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.
The Costs of Adverse Drug Events in Community Hospitals
Abstract
Background Adverse drug events (ADEs) occur often in hospitals, causing high morbidity and a longer length of stay (LOS), and are costly. However, most studies on the impact of ADEs have been conducted in tertiary referral centers, which are systematically different than community hospitals, where the bulk of care is delivered, and most available data about ADE costs in any setting are dated. Costs in community settings are generally lower than in academic hospitals, and the costs of ADEs might be as well. To assess the additional costs and LOS associated with patients with ADEs, a multicenter retrospective cohort study was conducted in six community hospitals with 100 to 300 beds in Massachusetts during a 20-month observation period (January 2005-August 2006).Methods A random sample of 2,100 patients (350 patients per study site) was drawn from a pool of 109,641 patients treated within the 20-month observation period. Unadjusted and adjusted cost of ADEs as well as LOS were calculated.Results ADEs were associated with an increased adjusted cost of $3,420 and an adjusted increase in length of stay (LOS) of 3.15 days. For preventable ADEs, the respective figures were +$3,511 and +3.37 days. The severity of the ADE was also associated with higher costs--the costs were +$2,852 for significant ADEs (LOS +2.77 days), +$3,650 for serious ADEs (LOS +3.47 days), and +$8,116 for life-threatening ADEs (LOS +5.54 days, all p < .001).Conclusions ADEs in community hospitals cost more than $3,000 dollars on average and an average increase of LOS of 3.1 days--increments that were similar to previous estimates from academic institutions. The LOS increase was actually greater. A number of approaches, including computerized provider order entry and bar coding, have the potential to improve medication safety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adverse drug events have been shown to increase both the cost and the length of stay in community hospitals (8).”
From Application of zero trust model in preventing medical errors (2024) · cites this paper as [8]
Citations
Cites
Institute of Medicine (2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,390
Wall, A. (2000) · British Journal of Healthcare Management · doi:10.12968/bjhc.2000.6.9.19311 · Cited by 5,912
The Nature of Adverse Events in Hospitalized Patients
Leape, L. L., Brennan, T. A., Laird, N. M., Lawthers, A. G., Localio, A. R., Barnes, B. A., Hebert, L. E., Newhouse, J. P., Weiler, P. C., & Hiatt, H. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240605 · Cited by 3,766
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
Classen, D. C. (1997) · JAMA · doi:10.1001/jama.277.4.301 · Cited by 1,897
Bates, D. W. (1997) · JAMA · doi:10.1001/jama.277.4.307 · Cited by 1,678
The Costs of Adverse Drug Events in Hospitalized Patients
Bates, D. W. (1997) · JAMA · doi:10.1001/jama.1997.03540280045032 · Cited by 1,072
Relationship between medication errors and adverse drug events
Bates, D. W., Boyle, D. L., Vliet, M. B. V., Schneider, J., & Leape, L. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02600255 · Cited by 981 · cited 2×
“DEFINITIONS A medication error is defined as an error anywhere in the process of ordering, delivering, or administering a drug.(16) An ADE is defined as a medication error with a drug actually harming the patient.”
BackgroundDrug-Related Problems in Hospitals
hl-Melcher, A. K. H., Schlienger, R. G., Lampert, M. L., Haschke, M., Drewe, J., & hl, S. K. H. (2007) · Drug Safety · doi:10.2165/00002018-200730050-00003 · Cited by 542
Cited by
Sorted by citations
Blumenthal, K. G., Peter, J. G., Trubiano, J. A., & Phillips, E. J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32218-9 · Cited by 614
Keers, R. N., Williams, S. D., Cooke, J., & Ashcroft, D. M. (2013) · Drug Safety · doi:10.1007/s40264-013-0090-2 · Cited by 516
Cadec: A corpus of adverse drug event annotations
Karimi, S., Metke‐Jimenez, A., Kemp, M., & Wang, C. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.03.010 · Cited by 281
Prgomet, M., Li, L., Niazkhani, Z., Georgiou, A., & Westbrook, J. I. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw145 · Cited by 243
Mangin, D. A., Bahat, G., Golomb, B. A., Mallery, L. H., Moorhouse, P. A., Onder, G., Petrović, M., & Garfinkel, D. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0554-2 · Cited by 237
Formica, D., Sultana, J., Cutroneo, P. M., Lucchesi, S., Angelica, R. M., Crisafulli, S., Ingrasciotta, Y., Salvo, F., Spina, E., & Trifirò, G. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1491547 · Cited by 211
Drug interaction alert override rates in the Meaningful Use era: No evidence of progress
Bryant, A. D., Fletcher, G. S., & Payne, T. H. (2014) · Applied Clinical Informatics · doi:10.4338/aci-2013-12-ra-0103 · Cited by 172
Clinical Errors and Medical Negligence
Oyebode, F. (2013) · Medical Principles and Practice · doi:10.1159/000346296 · Cited by 165
Economic impact of medication error: a systematic review
Walsh, E. K., Hansen, C. R., Sahm, L. J., Kearney, P. M., Doherty, E., & Bradley, C. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4188 · Cited by 164
Pharmacovigilance Using Clinical Notes
LePendu, P., Iyer, S. V., Bauer‐Mehren, A., Harpaz, R., Mortensen, J., Podchiyska, T., Ferris, T., & Shah, N. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.47 · Cited by 162
Text and Data Mining Techniques in Adverse Drug Reaction Detection
Karimi, S., Wang, C., Metke‐Jimenez, A., Gaire, R., & Paris, C. L. (2015) · ACM Computing Surveys · doi:10.1145/2719920 · Cited by 131
The Cost of Penicillin Allergy Evaluation
Blumenthal, K. G., Li, Y., Banerji, A., Yun, B. J., Long, A. A., & Walensky, R. P. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.08.006 · Cited by 125
Buckley, M. S., Harinstein, L. M., Clark, K. B., Smithburger, P. L., Eckhardt, D. J., Alexander, E., Devabhakthuni, S., Westley, C. A., David, B., & Kane‐Gill, S. L. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013507428 · Cited by 104
Interventions for reducing medication errors in children in hospital
Maaskant, J. M., Vermeulen, H., Apampa, B., Fernando, B., Ghaleb, M. A., Neubert, A. C., Thayyil, S., & Soe, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006208.pub3 · Cited by 92
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
Lauschke, V. M., & Ingelman‐Sundberg, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101714 · Cited by 92
Poudel, D. R., Acharya, P., Ghimire, S., Dhital, R., & Bharati, R. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4184 · Cited by 86
Excess length of stay and economic consequences of adverse events in Dutch hospital patients
Hoogervorst-Schilp, J., Langelaan, M., Spreeuwenberg, P. M. M., de Bruijne, M. C., & Wagner, C. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1205-5 · Cited by 85
Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients
Vermeulen, K. M., van Doormaal, J. E., Zaal, R. J., Mol, P. G. M., Lenderink, A. W., Haaijer‐Ruskamp, F. M., Kosterink, J. G. W., & van den Bemt, P. M. L. A. (2014) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2014.05.003 · Cited by 74
Pevnick, J. M., Nguyen, C., Jackevicius, C. A., Palmer, K. A., Shane, R. R., Cook‐Wiens, G., Rogatko, A., Bear, M. E., Rosen, O., Seki, D., et al. (2017) · BMJ Quality & Safety · doi:10.1136/bmjqs-2017-006761 · Cited by 70
Gyllensten, H., Hakkarainen, K. M., Hägg, S., Carlsten, A., Petzold, M., Rehnberg, C., & Jönsson, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092061 · Cited by 69
Slight, S. P., Seger, D. L., Franz, C., Wong, A., & Bates, D. W. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy066 · Cited by 67
Farag, A., Garg, A. X., Li, L., & Jain, A. K. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.09.009 · Cited by 65
Patient Experiences with Pharmacogenetic Testing in a Primary Care Setting
Haga, S. B., Mills, R. A., Moaddeb, J., LaPointe, N. M. A., Cho, A., & Ginsburg, G. S. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0077 · Cited by 60
A systematic review of observational studies evaluating costs of adverse drug reactions
Marques, F. B., Penedones, A., Mendes, D., & Alves, C. (2016) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s115689 · Cited by 56
Lim, Y.-J., Kim, H.-Y., Choi, J., Lee, J. S., Ahn, A.-L., Oh, E.-J., Cho, D.-Y., & Kweon, H.-J. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.6.329 · Cited by 52
Haines, H., Meyer, J., Summers, R., & Godman, B. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02862-8 · Cited by 40
Coloma, P. M., Schuemie, M. J., Trifirò, G., Furlong, L. I., van Mulligen, E. M., Bauer‐Mehren, A., Avillach, P., Kors, J. A., Sanz, F., Mestres, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072148 · Cited by 49
Drug-related mortality among inpatients: a retrospective observational study
Pardo-Cabello, A. J., Gavilán, E. D. P., Jiménez, F. J. G., Rodríguez, C. M., Luna, J. D. D., & Cañas, E. P. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2026-0 · Cited by 48
Redesigning the allergy module of the electronic health record.
Blumenthal, K., Park, M., & Macy, E. (2016) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2016.05.017 · Cited by 43
Safe Use of Electronic Health Records and Health Information Technology Systems
Denham, C. R., Classen, D. C., Swenson, S. J., Henderson, M. J., Zeltner, T. B., & Bates, D. W. (2013) · Journal of Patient Safety · doi:10.1097/pts.0b013e3182a8c2b2 · Cited by 46
Neville, H. L., Chevalier, B. A. M., Daley, C. J. A., Nodwell, L., Harding, C., Hiltz, A., MacDonald, T., Skedgel, C. D., MacKinnon, N. J., & Slayter, K. (2013) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12058 · Cited by 46
Categorization and association analysis of risk factors for adverse drug events
Zhou, L., & Rupa, A. P. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2373-5 · Cited by 46
Risør, B. W., Lisby, M., & Sørensen, J. (2017) · Value in Health · doi:10.1016/j.jval.2017.03.001 · Cited by 43
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
Lim, F., Bellows, B. K., Tan, S. X., Aziz, Z., Woo Baidal, J. A., Kelly, A. S., & Hur, C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.29178 · Cited by 42
Hernandez, F., Majoul, E., Montes-Palacios, C., Antignac, M., Cherrier, B., Doursounian, L., Féron, J.-M., Robert, C., Hejblum, G., Fernandez, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134101 · Cited by 42
Evaluating the costs of adverse drug events in hospitalized patients: a systematic review
Durand, M., Castelli, C., Roux‐Marson, C., Kinowski, J., & Leguelinel, G. (2024) · Health Economics Review · doi:10.1186/s13561-024-00481-y · Cited by 41
Medication errors among health professionals in Nigeria: A national survey
Ogunleye, O. O., Oreagba, I. A., Falade, C. O., Isah, A. O., Enwere, O. O., Olayemi, S. O., Ogundele, S. O., Obiako, R., Odesanya, R. U., Bassi, P. U., et al. (2016) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-160721 · Cited by 41
Nabovati, E., Vakili-Arki, H., Taherzadeh, Z., Hasibian, M. R., Abu–Hanna, A., & Eslami, S. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-52 · Cited by 39
Drug safety in acute migraine treatment
Tajti, J., Majláth, Z., Szok, D., Csáti, A., & Vécsei, L. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1026325 · Cited by 38
Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective
Gómez-Lumbreras, A., Tan, M. S., Zapata, L. V., Ilham, S., Earl, J. C., & Malone, D. C. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.03.012 · Cited by 37
Potentially inappropriate prescriptions in patients admitted to a psychiatric hospital
Soerensen, A. L., Nielsen, L. P., Poulsen, B. K., Lisby, M., & Mainz, J. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1127996 · Cited by 30
Cost-effectiveness analysis of a hospital electronic medication management system
Westbrook, J. I., Gospodarevskaya, E., Li, L., Richardson, K. L., Roffe, D., Heywood, M., Day, R. O., & Graves, N. (2015) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocu014 · Cited by 30
Kuklik, N., Stausberg, J., & Jöckel, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187510 · Cited by 29
Implementation strategies in the context of medication reconciliation: a qualitative study
Stolldorf, D. P., Ridner, S. H., Vogus, T. J., Roumie, C. L., Schnipper, J. L., Dietrich, M. S., Schlundt, D. G., & Kripalani, S. B. (2021) · Implementation Science Communications · doi:10.1186/s43058-021-00162-5 · Cited by 30
Skog, J., Rafie, S., Schnock, K. O., Yoon, C., Lipsitz, S. R., & Lew, P. (2021) · Journal of Patient Safety · doi:10.1097/pts.0000000000000905 · Cited by 28
Short-Term Outcomes Following Hip Fractures in Patients at Least 100 Years Old
Manoli, A., Driesman, A. S., Marwin, R. A., Konda, S. R., Leucht, P., & Egol, K. A. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.00697 · Cited by 28
Nguemeleu, E. T., Dubois, C., & D’Amour, D. (2017) · Journal of Advanced Nursing · doi:10.1111/jan.13260 · Cited by 27
Larmené‐Beld, K. H. M., Spronk, J. T., Luttjeboer, J., Taxis, K., & Postma, M. J. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.04.024 · Cited by 27
Effects of CPOE-based medication ordering on outcomes: an overview of systematic reviews
Abraham, J., Kitsiou, S., Meng, A., Burton, S., Vatani, H., & Kannampallil, T. (2020) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-010436 · Cited by 31
Clinical decision support systems: great promises for better management of patients’ drug therapy
Turgeon, J., & Michaud, V. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1171317 · Cited by 26
Severity and Management of Drug–Drug Interactions in Acute Geriatric Patients
Lea, M., Rognan, S. E., Koristovic, R., Wyller, T. B., & Molden, E. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0091-y · Cited by 25
Smith, L., Mosley, J., Lott, S., Ernie, C. Y. R., Amin, R., Everton, E. C., ISLAMI, A., Phan, L. D., & KOMOLAFE, O. (2015) · Pharmacy Practice · doi:10.18549/pharmpract.2015.04.634 · Cited by 25
Emergency Nurses as Second Victims of Error
Khameslou, M. A., Abbaszadeh, A., & Borhani, F. (2017) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0000000000000133 · Cited by 24
Leveraging MEDLINE indexing for pharmacovigilance – Inherent limitations and mitigation strategies
Winnenburg, R., Sorbello, A. F., Ripple, A., Harpaz, R., Tonning, J. M., Szarfman, A., Francis, H., & Bodenreider, O. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.08.022 · Cited by 23
Spector, W. D., Limcangco, R., Furukawa, M. F., & Encinosa, W. E. (2017) · Medical Care · doi:10.1097/mlr.0000000000000780 · Cited by 20
Ho, J., & Burger, D. M. (2020) · BMJ Open Quality · doi:10.1136/bmjoq-2020-000987 · Cited by 20
Concept Extraction to Identify Adverse Drug Reactions in Medical Forums: A Comparison of AlgorithmsPreprint
Metke‐Jimenez, A., & Karimi, S. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1504.06936 · Cited by 20
Partnered pharmacist medication charting and prescribing in Australian hospitals
Tong, E., & Yip, G. S. (2024) · Australian Prescriber · doi:10.18773/austprescr.2024.011 · Cited by 18
Anti-infective Acquisition Costs for a Stewardship Program: Getting to the Bottom Line
Parker, S. K., Hurst, A. L., Thurm, C. W., Millard, M., Jenkins, T. C., Child, J., & Dugan, C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix631 · Cited by 18
Fajreldines, A., Schnitzler, E. J., Torres, S., Panattieri, N. D., & Pellizzari, M. (2019) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2019.eng.e106 · Cited by 18
Nursing perception of risk in common nursing practice situations
Trevino, P., Green, A., Middaugh, D. J., Heo, S., Beverly, C. J., & Deshpande, J. K. (2017) · Journal of Healthcare Risk Management · doi:10.1002/jhrm.21283 · Cited by 20
Davazdahemami, B., & Delen, D. (2019) · Expert Systems with Applications · doi:10.1016/j.eswa.2019.01.006 · Cited by 17
Zimlichman, E., Keohane, C. A., Franz, C., Everett, W. L., Seger, D. L., Yoon, C. S., Leung, A. A. C., Cadet, B., Coffey, M., Kaufman, N. E., et al. (2013) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(13)39044-8 · Cited by 17
McCarthy, B. C., Tuiskula, K. A., Driscoll, T. P., & Davis, A. M. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160848 · Cited by 17
Vancomycin and the Risk of AKI: Now Clearer than Mississippi Mud
Nolin, T. D. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11011016 · Cited by 17
Nuckols, T. K., Asch, S. M., Patel, V. M., Keeler, E. B., Anderson, L., Buntin, M. B., & Escarce, J. J. (2015) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(15)41045-1 · Cited by 18
Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care
Arnold, R. J. G., Tang, J., Schrecker, J. P., & Hild, C. (2018) · Drugs - Real World Outcomes · doi:10.1007/s40801-018-0143-z · Cited by 16
Qualität 2030. Die umfassende Strategie für das Gesundheitswesen
Schrappe, M. (2014) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954661527 · Cited by 22
Valenza, P., McGinley, T. C., Feldman, J., Patel, P., Cornejo, K. M., Liang, N., Anmolsingh, R., & McNaughton, N. (2017) · InTech eBooks · doi:10.5772/intechopen.69169 · Cited by 15
McGinnis, B., Padilla‐Tolentino, E., Garret, P., & Aziz, S. M. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.01.019 · Cited by 15
Efficiency and Usability of a Near Field Communication-Enabled Tablet for Medication Administration
Landman, A., Neri, P. M., Robertson, A., McEvoy, D. S., Dinsmore, M., Sweet, M., Bane, A., Takhar, S. S., & Miles, S. B. (2014) · JMIR mhealth and uhealth · doi:10.2196/mhealth.3215 · Cited by 14
Aspinall, S. L., Vu, M., Moore, V. R., Jiang, R., Au, A., Bounthavong, M., & Glassman, P. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.47909 · Cited by 13
Convertino, I., Salvadori, S., Pecori, A., Galiulo, M. T., Ferraro, S., Parrilli, M., Corona, T., Turchetti, G., Blandizzi, C., & Tuccori, M. (2018) · Drug Safety · doi:10.1007/s40264-018-0737-0 · Cited by 13
Arora, P., Muehrcke, M., & Hertig, J. B. (2022) · Pain and Therapy · doi:10.1007/s40122-022-00402-z · Cited by 12
Langenberger, B. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15846 · Cited by 10
Norouzi, S., Galavi, Z., & Ahmadian, L. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02355-5 · Cited by 14
Benhamou, D., Weiss, M., Borms, M., Lucaci, J. D., Girgis, H., Frolet, C., Baisley, W. T., Shoushi, G., Cribbs, K. A., & Wenk, M. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231212890 · Cited by 12
Alwidyan, T., Odeh, M., Ibrahim, A. H., Harahsheh, E., & Banat, A. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100578 · Cited by 12
Potential cost savings by prevention of adverse drug events with a novel medication review program
Fernández, E. V., Warriner, C. L., David, T., Gordon, E., Twigg, G., & Carroll, N. V. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.12.004 · Cited by 12
Iyer, S. V., LePendu, P., Harpaz, R., Bauer‐Mehren, A., & Shah, N. H. (2013) · Europe PMC (PubMed Central) · Cited by 12
Risør, B. W., Lisby, M., & Sørensen, J. R. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0360-8 · Cited by 12
Saylor, A., Wallace, S. E., Brown, E. V. D., & Schreiber, J. B. (2021) · Aphasiology · doi:10.1080/02687038.2021.1873907 · Cited by 12
Medication Safety in Hospitals: Avoiding Medication Errors in the Medication use Process
(2013) · Advances in Pharmacoepidemiology & Drug Safety · doi:10.4172/2167-1052.1000134 · Cited by 12
Schrappe, M. (2014) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2082-5 · Cited by 11
Kuklik, N., Stausberg, J., Amiri, M., & Jöckel, K. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4381-x · Cited by 11
Evaluation of text-processing algorithms for adverse drug event extraction from social media
Metke‐Jimenez, A., Karimi, S., & Paris, C. L. (2014) · doi:10.1145/2632188.2632200 · Cited by 10
Medication Histories in Critically Ill Patients Completed by Pharmacy Personnel
Kram, B., Trammel, M. A., Kram, S. J., Wheeley, S. E., Mancheril, B. G., Burgess, L. D., & Schultheis, J. M. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028018825483 · Cited by 10
ANALYZING SEARCH BEHAVIOR OF HEALTHCARE PROFESSIONALS FOR DRUG SAFETY SURVEILLANCE
Odgers, D., Harpaz, R., Callahan, A., Štiglic, G., & Shah, N. H. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0030 · Cited by 10
Medication Harmony: A Framework to Save Time, Improve Accuracy and Increase Patient Activation.
Pandolfe, F., Crotty, B. H., & Safran, C. (2016) · PubMed Central · Cited by 10
Reducing Avoidable Medication-Related Harm: What Will it Take?
Tetteh, E. K. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.04.002 · Cited by 10
Simpson, K. N., Fossler, M. J., Wase, L., Demitrack, M. A., & Wandstrat, T. L. (2022) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2022.2038137 · Cited by 9
Automatic Detection of Adverse Drug Events in Geriatric Care: Study Proposal
Gaspar, F., Lutters, M., Beeler, P. E., Lang, P. O., Burnand, B., Rinaldi, F., Lovis, C., Csajka, C., Pogam, M. L., & study, S. (2022) · JMIR Research Protocols · doi:10.2196/40456 · Cited by 9
Sheikh, A., Coleman, J. J., Chuter, A., Williams, R., Lilford, R. J., Slee, A., Morrison, Z., Cresswell, K. M., Robertson, A. R. R., Slight, S. P., et al. (2022) · Programme Grants for Applied Research · doi:10.3310/ksrs2009 · Cited by 12
Dechanont, S., Jedsadayanmata, A., Butthum, B., & Kongkaew, C. (2019) · Journal of Patient Safety · doi:10.1097/pts.0000000000000627 · Cited by 9
Jang, I., Lee, Y. S., Jeon, M. K., Cho, H., Oh, J. S., Lee, Y., Park, H., Kim, S. H., & Lee, E. (2013) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2013.17.3.126 · Cited by 9
Comparing Methods for Estimating Direct Costs of Adverse Drug Events
Gyllensten, H., Jönsson, A. K., Hakkarainen, K. M., Svensson, S. A., Hägg, S., & Rehnberg, C. (2017) · Value in Health · doi:10.1016/j.jval.2017.06.007 · Cited by 9
Pandolfe, F., Wright, A. T., Slack, W. V., & Safran, C. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy047 · Cited by 8
Calculating the cost of medication errors: A systematic review of approaches and cost variables
Ranasinghe, S., Nadeshkumar, A., Senadheera, S. G., & Samaranayake, N. (2024) · BMJ Open Quality · doi:10.1136/bmjoq-2023-002570 · Cited by 7
Davazdahemami, B., & Delen, D. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.02.010 · Cited by 7
Evaluation of Pharmacovigilance System in Iran
Khalili, M., Sharifi, H. P., Mesgarpour, B., Kheirandish, M., Olsson, S., Javidnikou, N., & Haghdoost, A. A. (2020) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.243 · Cited by 7
Metadata
- Authors
- Hug, B. L., Keohane, C., Seger, D. L., Yoon, C., & Bates, D. W.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Bates, David W.
- Venue
- The Joint Commission Journal on Quality and Patient Safety
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 38
- Issue
- 3
- Pages
- 120-126
- ISSN
- 1553-7250 (ISSN-L)
- OpenAlex
- W315942296
- Cited by
- 169
- References
- 18
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 8 · 2019: 10 · 2018: 14 · 2017: 20 · 2016: 24 · 2015: 18 · 2014: 11 · 2013: 18 · 2012: 1
- FWCI
- 26.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Joint Commission Journal on Quality and Patient Safety (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brigham and Women’s Hospital (6029138)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- adverse drug reactions, community hospitals, hospital costs, length of hospital stay, preventable adverse drug events, drug safety, computerized physician order entry, barcoding
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Hospital Bed Capacity, 100 to 299, Hospitals, Community, Humans, Insurance, Health, Length of Stay, Male, Medication Errors, Middle Aged, Retrospective Studies, Hospital Costs, Hospital Charges, Racial Groups, Young Adult, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review